The first human pharmacokinetics study of Neurotech International’s broad-spectrum cannabinoid treatment, NTI164, has shown positive results […]
Author Archives: Steve Jones
Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades.
He is a regulator contributor to health journal, The Medical Republic, writing on issues including the National Disability Insurance Scheme, aged care, mental health and gene editing technology.
He has also held senior editorial roles at publications covering the travel, media and marketing industries.
